Key result
Higher S-wave amplitude in right precordial leads predicts ~118% greater odds of CRT response.
Why the study?
Current guideline criteria do not satisfactorily discriminate responders to CRT, and QRS amplitude might be key to optimal patient selection.
Does a prominent S-wave in right precordial leads predict response to cardiac resynchronization therapy in patients receiving guideline-indicated CRT?
Cohort (n=47)
Does a prominent S-wave in right precordial leads predict response to cardiac resynchronization therapy in patients receiving guideline-indicated CRT?
Answers are grounded in this paper and cite their sources.
A prominent S-wave in right precordial leads (≥1.44 mV) on baseline ECG is an independent predictor of echocardiographic and clinical response to cardiac resynchronization therapy.
Background and objectives: Current guidelines criteria do not satisfactorily discriminate responders to cardiac resynchronization therapy (CRT). QRS amplitude is an established index to recognize the severity of myocardial disturbance and might be a key to optimal patient selection for CRT. Materials and Methods: (1) Initial R-wave amplitude, (2) S-wave amplitude, and (3) a summation of maximal R- or R′-wave amplitude and S-wave amplitude were measured at baseline. These parameters were averaged according to right (V1 to V3) or left (V4 to V6) precordial leads. The impact of these parameters on response to CRT, which was defined as a decrease in left ventricular end-systolic volume ≥15% at six-month follow-up, was investigated. Results: Among 47 patients (71 years old, 28 men) who received guideline-indicated CRT implantation, 25 (53%) achieved the definition of CRT responder. Among baseline electrocardiogram parameters, only the higher S-wave amplitude in right precordial leads was an independent predictor of CRT responders (odds ratio: 2.181, 95% confidence interval: 1.078–4.414, p = 0.030) at a cutoff of 1.44 mV. The cutoff was independently associated with cumulative incidence of heart failure readmission and appropriate electrical defibrillation following CRT implantation (p < 0.05, respectively). Conclusions: Prominent S-wave in right precordial leads might be a promising index to predict left ventricular reverse remodeling and greater clinical outcomes following CRT implantation.
No takes yet. Share an insight, caveat, or question.
Kataoka et al. (2021) conducted a cohort in Heart failure requiring cardiac resynchronization therapy (n=47). Higher S-wave amplitude in right precordial leads was evaluated on Response to CRT (decrease in left ventricular end-systolic volume ≥15% at six-month follow-up) (OR 2.181, 95% CI 1.078-4.414, p=0.030). A higher S-wave amplitude in right precordial leads independently predicted response to cardiac resynchronization therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: